# AiCure

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/aicure

- Industry: Healthcare IT
- Headquarters: New York, US
- Website: www.aicure.com
- Total disclosed funding: $52M
- Latest round: Series C (Nov 7, 2019)
- Investors on record: 11

## About

Based in New York, US, and founded in 2010 by co-founders Adam Hanina, Laura Schafner, and Gordon Kessler, AiCure, LLC operates as a provider of artificial intelligence-based software and devices that help accelerate outcomes in the healthcare industry. In January 2024, AiCure, LLC raised USD 12 million in venture debt funding. The round was part of a larger USD 16 million equity and venture debt funding. 

AiCure, LLC offers artificial intelligence and data analytics solutions to improve patient engagement and monitoring in clinical trials. The company develops an interactive medical assistant that manages and monitors patients' disease and treatment. Its products include the eCOA-ePRO for capturing participant responses, Adherence & Dosing for managing medication adherence, and Patient Connect for real-time dosing instructions. In addition, the firm provides a platform that supports clinical site dashboards and services, providing data and insights to clinical teams. 

The company plans to use the funding from January 2024 to invest in research and development, expand operations, and enhance AiCure products and services.

## Funding rounds

- Series C, Nov 7, 2019, $25M — Baird Capital Partners, Pritzker Group Venture Capital, New Leaf Venture Partners, Palisades Growth Capital, Silicon Valley Bank, Asahi Kasei Corporation, Tribeca Venture Partners, Singtel Innov8, Accelmed, Biomatics Capital Partners, SpringRock Ventures
- Series B, Nov 17, 2017, $15M — Baird Capital Partners, Pritzker Group Venture Capital, New Leaf Venture Partners, Silicon Valley Bank, Tribeca Venture Partners, Biomatics Capital Partners
- Series A, Jan 11, 2016, $12M — Pritzker Group Venture Capital, New Leaf Venture Partners, Tribeca Venture Partners, Biomatics Capital Partners

## Investors

- Pritzker Group Venture Capital (https://capitalatlas.ai/funds/pritzker-group-venture-capital) — Series A, Series B, Series C
- New Leaf Venture Partners (https://capitalatlas.ai/funds/new-leaf-venture-partners) — Series A, Series B, Series C
- Tribeca Venture Partners (https://capitalatlas.ai/funds/tribeca-venture-partners) — Series A, Series B, Series C
- Biomatics Capital Partners (https://capitalatlas.ai/funds/biomatics-capital-partners) — Series A, Series B, Series C
- Baird Capital Partners (https://capitalatlas.ai/funds/baird-capital-partners) — Series B, Series C
- Silicon Valley Bank — Series B, Series C
- Palisades Growth Capital (https://capitalatlas.ai/funds/palisades-growth-capital) — Series C
- Asahi Kasei Corporation — Series C
- Singtel Innov8 (https://capitalatlas.ai/funds/singtel-innov8) — Series C
- Accelmed (https://capitalatlas.ai/funds/accelmed) — Series C
- SpringRock Ventures (https://capitalatlas.ai/funds/springrock-ventures) — Series C